chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: PAINFUL RASH; This spontaneous report received from a patient concerned a 31 year old female. The patient's weight was 155 pounds, and height was 167.64 centimeters. The patient's concurrent conditions included autoimmune celiac, gluten intolerant, and alcohol use, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: UNKNOWN) dose was not reported, administered on 16-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On 21-MAR-2021, the subject experienced painful rash. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from painful rash. This report was non-serious. Additional information received from patient on 25-Mar-2021. The following information was updated and incorporated into the case narrative: patient (weight, height, age at time of vaccination, patient history text), product (frequency time, vaccine military information) and due diligence correction made.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Vital signs measurement
Clinical narrative: HEART WAS RACING; BLOOD PRESSURE WAS 134/86; This spontaneous report received from a health care professional concerned a 49 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 23-MAR-2021 on right arm for prophylactic vaccination. No concomitant medications were reported. On 23-MAR-2021, the subject experienced heart was racing. Laboratory data included: Blood pressure (NR: not provided) 134/86 mmHg, and Heart rate (NR: not provided) 85-81 bpm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart was racing. This report was non-serious.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Heart rate, Palpitations
Clinical narrative: HEART WAS RACING; BLOOD PRESSURE WAS 134/86; This spontaneous report received from a health care professional concerned a 49 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 23-MAR-2021 on right arm for prophylactic vaccination. No concomitant medications were reported. On 23-MAR-2021, the subject experienced heart was racing. Laboratory data included: Blood pressure (NR: not provided) 134/86 mmHg, and Heart rate (NR: not provided) 85-81 bpm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart was racing. This report was non-serious.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Pallor, Vital signs measurement
Clinical narrative: APPEARED PALE; DIZZINESS; WEAKNESS; This spontaneous report received from a patient concerned a 32 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included arthritis, and fibromyalgia, and other pre-existing medical conditions included no allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805031, expiry: 26/MAY/2021) dose was not reported, administered on 19-MAR-2021 14:20 for prophylactic vaccination. Concomitant medications included celecoxib, cyclobenzaprine hydrochloride, lithium, and losartan. On 19-MAR-2021, Laboratory data included: Oxygen saturation (NR: not provided) Remained WNL. On 19-MAR-2021 14:35, the subject experienced appeared pale. On 19-MAR-2021 14:35, the subject experienced dizziness. On 19-MAR-2021 14:35, the subject experienced weakness. On 19-MAR-2021 14:40, Laboratory data included: Blood pressure (NR: not provided) 148/82 mmHg. On 19-MAR-2021 14:44, Laboratory data included: Blood pressure (NR: not provided) 142/86 mmHg. On 19-MAR-2021 14:46, Laboratory data included: Blood pressure (NR: not provided) 148/84 mmHg. On 19-MAR-2021 14:55, Laboratory data included: Blood pressure (NR: not provided) 142/94 mmHg. On 19-MAR-2021 15:00, Laboratory data included: Heart rate (NR: not provided) Remained WNL. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from appeared pale on MAR-2021, and dizziness, and weakness on 23-MAR-2021. This report was non-serious.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood pressure measurement, Dizziness, Heart rate, Oxygen saturation
Clinical narrative: APPEARED PALE; DIZZINESS; WEAKNESS; This spontaneous report received from a patient concerned a 32 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included arthritis, and fibromyalgia, and other pre-existing medical conditions included no allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805031, expiry: 26/MAY/2021) dose was not reported, administered on 19-MAR-2021 14:20 for prophylactic vaccination. Concomitant medications included celecoxib, cyclobenzaprine hydrochloride, lithium, and losartan. On 19-MAR-2021, Laboratory data included: Oxygen saturation (NR: not provided) Remained WNL. On 19-MAR-2021 14:35, the subject experienced appeared pale. On 19-MAR-2021 14:35, the subject experienced dizziness. On 19-MAR-2021 14:35, the subject experienced weakness. On 19-MAR-2021 14:40, Laboratory data included: Blood pressure (NR: not provided) 148/82 mmHg. On 19-MAR-2021 14:44, Laboratory data included: Blood pressure (NR: not provided) 142/86 mmHg. On 19-MAR-2021 14:46, Laboratory data included: Blood pressure (NR: not provided) 148/84 mmHg. On 19-MAR-2021 14:55, Laboratory data included: Blood pressure (NR: not provided) 142/94 mmHg. On 19-MAR-2021 15:00, Laboratory data included: Heart rate (NR: not provided) Remained WNL. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from appeared pale on MAR-2021, and dizziness, and weakness on 23-MAR-2021. This report was non-serious.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pallor
Clinical narrative: APPEARED PALE; DIZZINESS; WEAKNESS; This spontaneous report received from a patient concerned a 32 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included arthritis, and fibromyalgia, and other pre-existing medical conditions included no allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805031, expiry: 26/MAY/2021) dose was not reported, administered on 19-MAR-2021 14:20 for prophylactic vaccination. Concomitant medications included celecoxib, cyclobenzaprine hydrochloride, lithium, and losartan. On 19-MAR-2021, Laboratory data included: Oxygen saturation (NR: not provided) Remained WNL. On 19-MAR-2021 14:35, the subject experienced appeared pale. On 19-MAR-2021 14:35, the subject experienced dizziness. On 19-MAR-2021 14:35, the subject experienced weakness. On 19-MAR-2021 14:40, Laboratory data included: Blood pressure (NR: not provided) 148/82 mmHg. On 19-MAR-2021 14:44, Laboratory data included: Blood pressure (NR: not provided) 142/86 mmHg. On 19-MAR-2021 14:46, Laboratory data included: Blood pressure (NR: not provided) 148/84 mmHg. On 19-MAR-2021 14:55, Laboratory data included: Blood pressure (NR: not provided) 142/94 mmHg. On 19-MAR-2021 15:00, Laboratory data included: Heart rate (NR: not provided) Remained WNL. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from appeared pale on MAR-2021, and dizziness, and weakness on 23-MAR-2021. This report was non-serious.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: TINGLING OF FINGERS; SORE LEFT ARM; LOW GRADE FEVER; FATIGUE; This spontaneous report received from a patient concerned a 40 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021, the subject experienced tingling of fingers. On 13-MAR-2021, the subject experienced sore left arm. On 13-MAR-2021, the subject experienced low grade fever. On 13-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore left arm, low grade fever, and fatigue on 14-MAR-2021, and had not recovered from tingling of fingers. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard procedure as the case is assessed as Non-serious
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Pain in extremity, Paraesthesia, Pyrexia
Clinical narrative: TINGLING OF FINGERS; SORE LEFT ARM; LOW GRADE FEVER; FATIGUE; This spontaneous report received from a patient concerned a 40 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021, the subject experienced tingling of fingers. On 13-MAR-2021, the subject experienced sore left arm. On 13-MAR-2021, the subject experienced low grade fever. On 13-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore left arm, low grade fever, and fatigue on 14-MAR-2021, and had not recovered from tingling of fingers. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard procedure as the case is assessed as Non-serious
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Antipsychotic drug level, Full blood count, International normalised ratio, Limb discomfort
Clinical narrative: UNABLE TO WALK; GENERALISED PAIN; VASCULITIS; This spontaneous report received from a patient concerned a 63 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 13-MAR-2021on right deltoid arm for prophylactic vaccination . The batch was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced vasculitis. Laboratory data included: Pain scale (NR: not provided) 2/10. On 13-MAR-2021, the subject experienced generalised pain. Treatment medications included: paracetamol. On 19-MAR-2021, the subject experienced unable to walk. Laboratory data included: Pain scale (NR: not provided) 10/10. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from unable to walk on 24-MAR-2021, and generalised pain on 13-MAR-2021, and the outcome of vasculitis was not reported. This report was non-serious.; Sender's Comments: Report not required as per standard procedure as case was assessed as non-serious.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Peripheral swelling, Rash
Clinical narrative: UNABLE TO WALK; GENERALISED PAIN; VASCULITIS; This spontaneous report received from a patient concerned a 63 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 13-MAR-2021on right deltoid arm for prophylactic vaccination . The batch was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced vasculitis. Laboratory data included: Pain scale (NR: not provided) 2/10. On 13-MAR-2021, the subject experienced generalised pain. Treatment medications included: paracetamol. On 19-MAR-2021, the subject experienced unable to walk. Laboratory data included: Pain scale (NR: not provided) 10/10. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from unable to walk on 24-MAR-2021, and generalised pain on 13-MAR-2021, and the outcome of vasculitis was not reported. This report was non-serious.; Sender's Comments: Report not required as per standard procedure as case was assessed as non-serious.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gait inability, Pain, Pain assessment, Vasculitis
Clinical narrative: UNABLE TO WALK; GENERALISED PAIN; VASCULITIS; This spontaneous report received from a patient concerned a 63 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 13-MAR-2021on right deltoid arm for prophylactic vaccination . The batch was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced vasculitis. Laboratory data included: Pain scale (NR: not provided) 2/10. On 13-MAR-2021, the subject experienced generalised pain. Treatment medications included: paracetamol. On 19-MAR-2021, the subject experienced unable to walk. Laboratory data included: Pain scale (NR: not provided) 10/10. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from unable to walk on 24-MAR-2021, and generalised pain on 13-MAR-2021, and the outcome of vasculitis was not reported. This report was non-serious.; Sender's Comments: Report not required as per standard procedure as case was assessed as non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: OFF LABEL USE; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE; This spontaneous report received from a health care professional concerned a 16 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021, on the left deltoid, for prophylactic vaccination. No concomitant medications were reported. On 25-MAR-2021, the subject experienced off label use. On 25-MAR-2021, the subject experienced product administered to subject of inappropriate age. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the product administered to patient of inappropriate age and off label use was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Off label use, Product administered to patient of inappropriate age
Clinical narrative: OFF LABEL USE; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE; This spontaneous report received from a health care professional concerned a 16 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021, on the left deltoid, for prophylactic vaccination. No concomitant medications were reported. On 25-MAR-2021, the subject experienced off label use. On 25-MAR-2021, the subject experienced product administered to subject of inappropriate age. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the product administered to patient of inappropriate age and off label use was not reported. This report was non-serious.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect route of product administration, Injection site bruising, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: LUMP ABOUT THE SIZE OF AN ALMOND FORMED TWO INCHES BELOW THE INJECTION SITE; LUMP PAINFUL TO TOUCH; RASH AT INJECTION SITE; LIGHT BRUISE AT LUMP; This spontaneous report received from a patient concerned a 46 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072, expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced light bruise at lump. On 10-MAR-2021, the subject experienced lump about the size of an almond formed two inches below the injection site. On 10-MAR-2021, the subject experienced lump painful to touch. On 10-MAR-2021, the subject experienced rash at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from rash at injection site, and had not recovered from lump painful to touch, lump about the size of an almond formed two inches below the injection site, and light bruise at lump. This report was non-serious.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Contusion, Injection site rash, Mass, Pain
Clinical narrative: LUMP ABOUT THE SIZE OF AN ALMOND FORMED TWO INCHES BELOW THE INJECTION SITE; LUMP PAINFUL TO TOUCH; RASH AT INJECTION SITE; LIGHT BRUISE AT LUMP; This spontaneous report received from a patient concerned a 46 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072, expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced light bruise at lump. On 10-MAR-2021, the subject experienced lump about the size of an almond formed two inches below the injection site. On 10-MAR-2021, the subject experienced lump painful to touch. On 10-MAR-2021, the subject experienced rash at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from rash at injection site, and had not recovered from lump painful to touch, lump about the size of an almond formed two inches below the injection site, and light bruise at lump. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 22234, and batch number: 22234 expiry: 21/MAY/2021) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache. This report was non-serious.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient husband was returning to pharmacy for his second dose of Covid19 vaccine and advised pharmacy that his wife received her first Covid19 vaccine on 4-2-21 and on the evening of 4-3-21 she died in the hospital/ER of unknown cause.  The patient advised the pharmacy that the doctor was unsure of cause of death, but suspected a stroke or TIA.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Death
Clinical narrative: Patient husband was returning to pharmacy for his second dose of Covid19 vaccine and advised pharmacy that his wife received her first Covid19 vaccine on 4-2-21 and on the evening of 4-3-21 she died in the hospital/ER of unknown cause.  The patient advised the pharmacy that the doctor was unsure of cause of death, but suspected a stroke or TIA.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Seizure, Syncope
Clinical narrative: Patient at pharmacy and sitting in chair after receiving vaccine.  Patient slumped in his chair and had seizure x 2, incontinent of urine.  Patient to ER and neurology consult..  Neurology diagnosed convulsive syncope.  No further treatment.  Patient discharged home.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram head, Seizure, Urge incontinence
Clinical narrative: Patient at pharmacy and sitting in chair after receiving vaccine.  Patient slumped in his chair and had seizure x 2, incontinent of urine.  Patient to ER and neurology consult..  Neurology diagnosed convulsive syncope.  No further treatment.  Patient discharged home.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Client given dose of vaccine that was diluted using sterile water instead of normal saline. Client re-vaccinated 4/24/2021 at 1100 using Pfizer ER8736, expiration 7/31/2021.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immunisation, Product preparation issue
Clinical narrative: Client given dose of vaccine that was diluted using sterile water instead of normal saline. Client re-vaccinated 4/24/2021 at 1100 using Pfizer ER8736, expiration 7/31/2021.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anion gap increased, Blood potassium decreased, Blood test, Chest X-ray normal, Chest pain
Clinical narrative: Patient received first dose of Moderna COVID-19 vaccine on 4/7/2021. Vaccine given 1547. Patient complained of sweating, blurry vision, and chest tightness. She was evaluated by  CRNP, Dr., and  RN. BP 98/70 and came up to 128/72 without intervention. Patient refused to lay flat. EMS also evaluated patient and took her to ED.  Second dose of Moderna should be given in monitored setting.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Disturbance in attention, Dizziness, Dyspnoea, Electrocardiogram, Feeling abnormal
Clinical narrative: Patient received first dose of Moderna COVID-19 vaccine on 4/7/2021. Vaccine given 1547. Patient complained of sweating, blurry vision, and chest tightness. She was evaluated by  CRNP, Dr., and  RN. BP 98/70 and came up to 128/72 without intervention. Patient refused to lay flat. EMS also evaluated patient and took her to ED.  Second dose of Moderna should be given in monitored setting.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling cold, Headache, Heart rate increased, Hypotension, Immediate post-injection reaction
Clinical narrative: Patient received first dose of Moderna COVID-19 vaccine on 4/7/2021. Vaccine given 1547. Patient complained of sweating, blurry vision, and chest tightness. She was evaluated by  CRNP, Dr., and  RN. BP 98/70 and came up to 128/72 without intervention. Patient refused to lay flat. EMS also evaluated patient and took her to ED.  Second dose of Moderna should be given in monitored setting.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lethargy, Lymphocyte percentage increased, Nausea, Retching, Tachycardia
Clinical narrative: Patient received first dose of Moderna COVID-19 vaccine on 4/7/2021. Vaccine given 1547. Patient complained of sweating, blurry vision, and chest tightness. She was evaluated by  CRNP, Dr., and  RN. BP 98/70 and came up to 128/72 without intervention. Patient refused to lay flat. EMS also evaluated patient and took her to ED.  Second dose of Moderna should be given in monitored setting.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: Patient received first dose of Moderna COVID-19 vaccine on 4/7/2021. Vaccine given 1547. Patient complained of sweating, blurry vision, and chest tightness. She was evaluated by  CRNP, Dr., and  RN. BP 98/70 and came up to 128/72 without intervention. Patient refused to lay flat. EMS also evaluated patient and took her to ED.  Second dose of Moderna should be given in monitored setting.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Hyperhidrosis, Vision blurred
Clinical narrative: Patient received first dose of Moderna COVID-19 vaccine on 4/7/2021. Vaccine given 1547. Patient complained of sweating, blurry vision, and chest tightness. She was evaluated by  CRNP, Dr., and  RN. BP 98/70 and came up to 128/72 without intervention. Patient refused to lay flat. EMS also evaluated patient and took her to ED.  Second dose of Moderna should be given in monitored setting.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Chills, Dyspnoea, Fatigue, Hallucination
Clinical narrative: BODY ACHES; INSOMNIA; CHILLS; LACK OF ENERGY; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on left arm on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, insomnia, chills, lack of energy, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body aches, nausea, chills, insomnia and lack of energy was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Lethargy, Mobility decreased, Oropharyngeal pain, Pain
Clinical narrative: BODY ACHES; INSOMNIA; CHILLS; LACK OF ENERGY; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on left arm on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, insomnia, chills, lack of energy, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body aches, nausea, chills, insomnia and lack of energy was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Rash, Rhinorrhoea, Tinnitus
Clinical narrative: BODY ACHES; INSOMNIA; CHILLS; LACK OF ENERGY; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on left arm on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, insomnia, chills, lack of energy, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body aches, nausea, chills, insomnia and lack of energy was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chills, Insomnia, Nausea, Pain
Clinical narrative: BODY ACHES; INSOMNIA; CHILLS; LACK OF ENERGY; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on left arm on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, insomnia, chills, lack of energy, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body aches, nausea, chills, insomnia and lack of energy was not reported. This report was non-serious.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Fatigue, Palpitations, Tinnitus
Clinical narrative: BODY ACHE; CHILLS; SORE ARM; FATIGUE; This spontaneous report received from a patient concerned a 50 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included obesity, cardiac condition, and asthma. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. The patient vaccinated on right arm. No concomitant medications were reported. On NOV-2020, Laboratory data included: PCR (NR: not provided) Negative. On 14-MAR-2021, the subject experienced body ache. On 14-MAR-2021, the subject experienced chills. On 14-MAR-2021, the subject experienced sore arm. On 14-MAR-2021, the subject experienced deep fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on MAR-2021, and had not recovered from body ache, chills, and deep fatigue. This report was non-serious.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Pain, Pain in extremity, Polymerase chain reaction
Clinical narrative: BODY ACHE; CHILLS; SORE ARM; FATIGUE; This spontaneous report received from a patient concerned a 50 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included obesity, cardiac condition, and asthma. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. The patient vaccinated on right arm. No concomitant medications were reported. On NOV-2020, Laboratory data included: PCR (NR: not provided) Negative. On 14-MAR-2021, the subject experienced body ache. On 14-MAR-2021, the subject experienced chills. On 14-MAR-2021, the subject experienced sore arm. On 14-MAR-2021, the subject experienced deep fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on MAR-2021, and had not recovered from body ache, chills, and deep fatigue. This report was non-serious.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardio-respiratory arrest, Death, Dyspnoea, Foaming at mouth, Full blood count
Clinical narrative: PATIENT CODED; SHORTNESS OF BREATH; FOAMING AT MOUTH; PINK SPUTUM; This spontaneous report received from a health care professional (registered nurse) concerned a 66 year old male. Initial information was processed with additional information received from a healthcare professional on 13-APR-2021. The reporter reported to VAERS (no reference number provided). The patient's height, and weight were not reported. The patient's medical history included cancer (not further specified).  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, 1 total, administered to right deltoid on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. An unspecified amount of time after vaccination, the patient was experiencing shortness of breath, and foaming at mouth. It was reported the patient "coded" at home (captured as cardiopulmonary arrest) and was brought in unresponsive with pink sputum to the emergency department around 1:00 am on 13-APR-2021. Platelets were 129 (normal range and units not reported). Additional tests heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. On 13-APR-2021 at 2:06 am the patient was pronounced dead. An autopsy was planned. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient outcome for cardiopulmonary arrest was fatal and for shortness of breath, foaming at mouth, pink sputum was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0 This report concerns a 66-year-old male patient who died (coded) a day after receiving Jansen COVID-19 vaccine.  At an unspecified time, the patient experienced SOB and foaming at mouth. On 13-APR-2021 (one day after vaccination), the patient was "coded" at home and was brought in unresponsive with pink sputum to the ER around 1:00 am. At 2:06 am the patient was pronounced dead. The platelet was 129 (unit unspecified), heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. This case has insufficient information to make a meaningful medical assessment. Additional information has been requested including autopsy findings.; Reported Cause(s) of Death: CARDIOPULMONARY ARREST
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: HIV test, Haemoglobin decreased, Loss of consciousness, Malaise, Metabolic function test
Clinical narrative: PATIENT CODED; SHORTNESS OF BREATH; FOAMING AT MOUTH; PINK SPUTUM; This spontaneous report received from a health care professional (registered nurse) concerned a 66 year old male. Initial information was processed with additional information received from a healthcare professional on 13-APR-2021. The reporter reported to VAERS (no reference number provided). The patient's height, and weight were not reported. The patient's medical history included cancer (not further specified).  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, 1 total, administered to right deltoid on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. An unspecified amount of time after vaccination, the patient was experiencing shortness of breath, and foaming at mouth. It was reported the patient "coded" at home (captured as cardiopulmonary arrest) and was brought in unresponsive with pink sputum to the emergency department around 1:00 am on 13-APR-2021. Platelets were 129 (normal range and units not reported). Additional tests heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. On 13-APR-2021 at 2:06 am the patient was pronounced dead. An autopsy was planned. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient outcome for cardiopulmonary arrest was fatal and for shortness of breath, foaming at mouth, pink sputum was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0 This report concerns a 66-year-old male patient who died (coded) a day after receiving Jansen COVID-19 vaccine.  At an unspecified time, the patient experienced SOB and foaming at mouth. On 13-APR-2021 (one day after vaccination), the patient was "coded" at home and was brought in unresponsive with pink sputum to the ER around 1:00 am. At 2:06 am the patient was pronounced dead. The platelet was 129 (unit unspecified), heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. This case has insufficient information to make a meaningful medical assessment. Additional information has been requested including autopsy findings.; Reported Cause(s) of Death: CARDIOPULMONARY ARREST
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Sputum discoloured
Clinical narrative: PATIENT CODED; SHORTNESS OF BREATH; FOAMING AT MOUTH; PINK SPUTUM; This spontaneous report received from a health care professional (registered nurse) concerned a 66 year old male. Initial information was processed with additional information received from a healthcare professional on 13-APR-2021. The reporter reported to VAERS (no reference number provided). The patient's height, and weight were not reported. The patient's medical history included cancer (not further specified).  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, 1 total, administered to right deltoid on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. An unspecified amount of time after vaccination, the patient was experiencing shortness of breath, and foaming at mouth. It was reported the patient "coded" at home (captured as cardiopulmonary arrest) and was brought in unresponsive with pink sputum to the emergency department around 1:00 am on 13-APR-2021. Platelets were 129 (normal range and units not reported). Additional tests heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. On 13-APR-2021 at 2:06 am the patient was pronounced dead. An autopsy was planned. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient outcome for cardiopulmonary arrest was fatal and for shortness of breath, foaming at mouth, pink sputum was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0 This report concerns a 66-year-old male patient who died (coded) a day after receiving Jansen COVID-19 vaccine.  At an unspecified time, the patient experienced SOB and foaming at mouth. On 13-APR-2021 (one day after vaccination), the patient was "coded" at home and was brought in unresponsive with pink sputum to the ER around 1:00 am. At 2:06 am the patient was pronounced dead. The platelet was 129 (unit unspecified), heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. This case has insufficient information to make a meaningful medical assessment. Additional information has been requested including autopsy findings.; Reported Cause(s) of Death: CARDIOPULMONARY ARREST
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardio-respiratory arrest, Coagulation test, Dyspnoea, Foaming at mouth, Heparin-induced thrombocytopenia test
Clinical narrative: PATIENT CODED; SHORTNESS OF BREATH; FOAMING AT MOUTH; PINK SPUTUM; This spontaneous report received from a health care professional (registered nurse) concerned a 66 year old male. Initial information was processed with additional information received from a healthcare professional on 13-APR-2021. The reporter reported to VAERS (no reference number provided). The patient's height, and weight were not reported. The patient's medical history included cancer (not further specified).  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, 1 total, administered to right deltoid on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. An unspecified amount of time after vaccination, the patient was experiencing shortness of breath, and foaming at mouth. It was reported the patient "coded" at home (captured as cardiopulmonary arrest) and was brought in unresponsive with pink sputum to the emergency department around 1:00 am on 13-APR-2021. Platelets were 129 (normal range and units not reported). Additional tests heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. On 13-APR-2021 at 2:06 am the patient was pronounced dead. An autopsy was planned. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient outcome for cardiopulmonary arrest was fatal and for shortness of breath, foaming at mouth, pink sputum was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0 This report concerns a 66-year-old male patient who died (coded) a day after receiving Jansen COVID-19 vaccine.  At an unspecified time, the patient experienced SOB and foaming at mouth. On 13-APR-2021 (one day after vaccination), the patient was "coded" at home and was brought in unresponsive with pink sputum to the ER around 1:00 am. At 2:06 am the patient was pronounced dead. The platelet was 129 (unit unspecified), heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. This case has insufficient information to make a meaningful medical assessment. Additional information has been requested including autopsy findings.; Reported Cause(s) of Death: CARDIOPULMONARY ARREST
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count, Sputum discoloured
Clinical narrative: PATIENT CODED; SHORTNESS OF BREATH; FOAMING AT MOUTH; PINK SPUTUM; This spontaneous report received from a health care professional (registered nurse) concerned a 66 year old male. Initial information was processed with additional information received from a healthcare professional on 13-APR-2021. The reporter reported to VAERS (no reference number provided). The patient's height, and weight were not reported. The patient's medical history included cancer (not further specified).  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, 1 total, administered to right deltoid on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. An unspecified amount of time after vaccination, the patient was experiencing shortness of breath, and foaming at mouth. It was reported the patient "coded" at home (captured as cardiopulmonary arrest) and was brought in unresponsive with pink sputum to the emergency department around 1:00 am on 13-APR-2021. Platelets were 129 (normal range and units not reported). Additional tests heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. On 13-APR-2021 at 2:06 am the patient was pronounced dead. An autopsy was planned. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient outcome for cardiopulmonary arrest was fatal and for shortness of breath, foaming at mouth, pink sputum was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0 This report concerns a 66-year-old male patient who died (coded) a day after receiving Jansen COVID-19 vaccine.  At an unspecified time, the patient experienced SOB and foaming at mouth. On 13-APR-2021 (one day after vaccination), the patient was "coded" at home and was brought in unresponsive with pink sputum to the ER around 1:00 am. At 2:06 am the patient was pronounced dead. The platelet was 129 (unit unspecified), heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. This case has insufficient information to make a meaningful medical assessment. Additional information has been requested including autopsy findings.; Reported Cause(s) of Death: CARDIOPULMONARY ARREST
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count, Pulmonary embolism, Thrombocytopenia
Clinical narrative: PATIENT CODED; SHORTNESS OF BREATH; FOAMING AT MOUTH; PINK SPUTUM; This spontaneous report received from a health care professional (registered nurse) concerned a 66 year old male. Initial information was processed with additional information received from a healthcare professional on 13-APR-2021. The reporter reported to VAERS (no reference number provided). The patient's height, and weight were not reported. The patient's medical history included cancer (not further specified).  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, 1 total, administered to right deltoid on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. An unspecified amount of time after vaccination, the patient was experiencing shortness of breath, and foaming at mouth. It was reported the patient "coded" at home (captured as cardiopulmonary arrest) and was brought in unresponsive with pink sputum to the emergency department around 1:00 am on 13-APR-2021. Platelets were 129 (normal range and units not reported). Additional tests heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. On 13-APR-2021 at 2:06 am the patient was pronounced dead. An autopsy was planned. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient outcome for cardiopulmonary arrest was fatal and for shortness of breath, foaming at mouth, pink sputum was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0 This report concerns a 66-year-old male patient who died (coded) a day after receiving Jansen COVID-19 vaccine.  At an unspecified time, the patient experienced SOB and foaming at mouth. On 13-APR-2021 (one day after vaccination), the patient was "coded" at home and was brought in unresponsive with pink sputum to the ER around 1:00 am. At 2:06 am the patient was pronounced dead. The platelet was 129 (unit unspecified), heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. This case has insufficient information to make a meaningful medical assessment. Additional information has been requested including autopsy findings.; Reported Cause(s) of Death: CARDIOPULMONARY ARREST